AgenDx Biosciences Company
AgenDx is an early stage molecular diagnostics company develops a revolutionary cost-effective molecular diagnostics platform.
Industry:
Deep Diagnostics
Last Funding Type:
Post-IPO Debt
Funding Status:
Seed
Estimated Revenue:
$1M to $10M
Total Funding:
$39.4M
Investors Number:
2
Headquarters:
South Bend, Indiana, United States
Technology:
Genetic Test & Molecular Diagnostics
Investor Type:
For Profit
Founded Date:
01.01.2014
Employee Number:
1-10